However, its effect was modest in obese patients (Mantzoros ' Flier, 2000), most of whom were considered to be in a state of leptin resistance and unable to adequately respond to the anti-obesity signals of leptin (Münzberg ' Myers, 2005). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.